Ameritas Investment Partners’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Ameritas Investment Partners’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-995	Closed	-$2K	–	3370
2022 Q1	$2K	Hold	995	–	–	﹤0.01%	3059
2021 Q4	$2K	Hold	995	–	–	﹤0.01%	3099
2021 Q3	$5K	Hold	995	–	–	﹤0.01%	3039
2021 Q2	$7K	Hold	995	–	–	﹤0.01%	2979
2021 Q1	$8K	Buy	995 +550	+124%	+$5.99K	﹤0.01%	2937
2020 Q4	$4K	Hold	445	–	–	﹤0.01%	3016
2020 Q3	$5K	Hold	445	–	–	﹤0.01%	2996
2020 Q2	$3K	Hold	445	–	–	﹤0.01%	3031
2020 Q1	$3K	Hold	445	–	–	﹤0.01%	2942
2019 Q4	$2K	Hold	445	–	–	﹤0.01%	2989
2019 Q3	$3K	Hold	445	–	–	﹤0.01%	3002
2019 Q2	$5K	Buy	+445	New	+$6.48K	﹤0.01%	2959

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ameritas Investment Partners's KLDO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 995 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $8K in Q1 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Ameritas Investment Partners reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 995 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $2K.
Ameritas Investment Partners first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
Ameritas Investment Partners's Kaleido Biosciences, Inc. Common Stock position peaked at $8K in Q1 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.